Cargando…
Post-transplantation plasma malondialdehyde is associated with cardiovascular mortality in renal transplant recipients: a prospective cohort study
BACKGROUND: In renal transplant recipients (RTRs), cardiovascular mortality is the most common cause of long-term renal graft loss. Oxidative stress (OS) has been associated with cardiovascular disease and is known to be enhanced in RTRs. We aimed to prospectively investigate whether the concentrati...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056950/ https://www.ncbi.nlm.nih.gov/pubmed/32133530 http://dx.doi.org/10.1093/ndt/gfz288 |
_version_ | 1783503565805846528 |
---|---|
author | Yepes-Calderón, Manuela Sotomayor, Camilo G Gans, Rijk O B Berger, Stefan P Leuvenink, Henri G D Tsikas, Dimitrios Rodrigo, Ramón Navis, Gerjan J Bakker, Stephan J L |
author_facet | Yepes-Calderón, Manuela Sotomayor, Camilo G Gans, Rijk O B Berger, Stefan P Leuvenink, Henri G D Tsikas, Dimitrios Rodrigo, Ramón Navis, Gerjan J Bakker, Stephan J L |
author_sort | Yepes-Calderón, Manuela |
collection | PubMed |
description | BACKGROUND: In renal transplant recipients (RTRs), cardiovascular mortality is the most common cause of long-term renal graft loss. Oxidative stress (OS) has been associated with cardiovascular disease and is known to be enhanced in RTRs. We aimed to prospectively investigate whether the concentration of the OS biomarker malondialdehyde (MDA) is associated with long-term risk of cardiovascular mortality in a large cohort of RTRs. METHODS: The plasma MDA concentration was measured using the thiobarbituric acid reaction assay in 604 extensively phenotyped RTRs with a functioning allograft for ≥1 year. The association between MDA and cardiovascular mortality was assessed using Cox proportional hazard regression analyses in the overall cohort and within subgroups according to significant effect modifiers. RESULTS: Median circulating MDA concentration at baseline was 5.38 [interquartile range (IQR) 4.31–6.45] μmol/L. During a follow-up period of 6.4 (IQR 5.6–6.8) years, 110 (18%) RTRs died, with 40% of deaths due to cardiovascular causes. MDA concentration was significantly associated with the risk for cardiovascular mortality {hazard ratio [HR] 1.31 [95% confidence interval (CI) 1.03–1.67] per 1-SD increment}, independent of adjustment for potential confounders, including renal function, immunosuppressive therapy, smoking status and blood pressure. The association between MDA concentration and the risk for cardiovascular mortality was stronger in RTRs with relatively lower plasma ascorbic acid concentrations [≤42.5 µmol/L; HR 1.79 (95% CI 1.30–2.48) per 1-SD increment] or relatively lower estimated glomerular filtration rates [≤45 mL/min/1.73 m(2); HR 2.09 (95% CI 1.45–3.00) per 1-SD increment]. CONCLUSIONS: Circulating MDA concentration is independently associated with long-term risk for cardiovascular mortality, particularly in RTRs with relatively lower ascorbic acid concentrations or renal function. Further studies are warranted to elucidate whether OS-targeted interventions could decrease cardiovascular mortality in RTRs. |
format | Online Article Text |
id | pubmed-7056950 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-70569502020-03-10 Post-transplantation plasma malondialdehyde is associated with cardiovascular mortality in renal transplant recipients: a prospective cohort study Yepes-Calderón, Manuela Sotomayor, Camilo G Gans, Rijk O B Berger, Stefan P Leuvenink, Henri G D Tsikas, Dimitrios Rodrigo, Ramón Navis, Gerjan J Bakker, Stephan J L Nephrol Dial Transplant Original Articles BACKGROUND: In renal transplant recipients (RTRs), cardiovascular mortality is the most common cause of long-term renal graft loss. Oxidative stress (OS) has been associated with cardiovascular disease and is known to be enhanced in RTRs. We aimed to prospectively investigate whether the concentration of the OS biomarker malondialdehyde (MDA) is associated with long-term risk of cardiovascular mortality in a large cohort of RTRs. METHODS: The plasma MDA concentration was measured using the thiobarbituric acid reaction assay in 604 extensively phenotyped RTRs with a functioning allograft for ≥1 year. The association between MDA and cardiovascular mortality was assessed using Cox proportional hazard regression analyses in the overall cohort and within subgroups according to significant effect modifiers. RESULTS: Median circulating MDA concentration at baseline was 5.38 [interquartile range (IQR) 4.31–6.45] μmol/L. During a follow-up period of 6.4 (IQR 5.6–6.8) years, 110 (18%) RTRs died, with 40% of deaths due to cardiovascular causes. MDA concentration was significantly associated with the risk for cardiovascular mortality {hazard ratio [HR] 1.31 [95% confidence interval (CI) 1.03–1.67] per 1-SD increment}, independent of adjustment for potential confounders, including renal function, immunosuppressive therapy, smoking status and blood pressure. The association between MDA concentration and the risk for cardiovascular mortality was stronger in RTRs with relatively lower plasma ascorbic acid concentrations [≤42.5 µmol/L; HR 1.79 (95% CI 1.30–2.48) per 1-SD increment] or relatively lower estimated glomerular filtration rates [≤45 mL/min/1.73 m(2); HR 2.09 (95% CI 1.45–3.00) per 1-SD increment]. CONCLUSIONS: Circulating MDA concentration is independently associated with long-term risk for cardiovascular mortality, particularly in RTRs with relatively lower ascorbic acid concentrations or renal function. Further studies are warranted to elucidate whether OS-targeted interventions could decrease cardiovascular mortality in RTRs. Oxford University Press 2020-03-05 /pmc/articles/PMC7056950/ /pubmed/32133530 http://dx.doi.org/10.1093/ndt/gfz288 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Articles Yepes-Calderón, Manuela Sotomayor, Camilo G Gans, Rijk O B Berger, Stefan P Leuvenink, Henri G D Tsikas, Dimitrios Rodrigo, Ramón Navis, Gerjan J Bakker, Stephan J L Post-transplantation plasma malondialdehyde is associated with cardiovascular mortality in renal transplant recipients: a prospective cohort study |
title | Post-transplantation plasma malondialdehyde is associated with cardiovascular mortality in renal transplant recipients: a prospective cohort study |
title_full | Post-transplantation plasma malondialdehyde is associated with cardiovascular mortality in renal transplant recipients: a prospective cohort study |
title_fullStr | Post-transplantation plasma malondialdehyde is associated with cardiovascular mortality in renal transplant recipients: a prospective cohort study |
title_full_unstemmed | Post-transplantation plasma malondialdehyde is associated with cardiovascular mortality in renal transplant recipients: a prospective cohort study |
title_short | Post-transplantation plasma malondialdehyde is associated with cardiovascular mortality in renal transplant recipients: a prospective cohort study |
title_sort | post-transplantation plasma malondialdehyde is associated with cardiovascular mortality in renal transplant recipients: a prospective cohort study |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056950/ https://www.ncbi.nlm.nih.gov/pubmed/32133530 http://dx.doi.org/10.1093/ndt/gfz288 |
work_keys_str_mv | AT yepescalderonmanuela posttransplantationplasmamalondialdehydeisassociatedwithcardiovascularmortalityinrenaltransplantrecipientsaprospectivecohortstudy AT sotomayorcamilog posttransplantationplasmamalondialdehydeisassociatedwithcardiovascularmortalityinrenaltransplantrecipientsaprospectivecohortstudy AT gansrijkob posttransplantationplasmamalondialdehydeisassociatedwithcardiovascularmortalityinrenaltransplantrecipientsaprospectivecohortstudy AT bergerstefanp posttransplantationplasmamalondialdehydeisassociatedwithcardiovascularmortalityinrenaltransplantrecipientsaprospectivecohortstudy AT leuveninkhenrigd posttransplantationplasmamalondialdehydeisassociatedwithcardiovascularmortalityinrenaltransplantrecipientsaprospectivecohortstudy AT tsikasdimitrios posttransplantationplasmamalondialdehydeisassociatedwithcardiovascularmortalityinrenaltransplantrecipientsaprospectivecohortstudy AT rodrigoramon posttransplantationplasmamalondialdehydeisassociatedwithcardiovascularmortalityinrenaltransplantrecipientsaprospectivecohortstudy AT navisgerjanj posttransplantationplasmamalondialdehydeisassociatedwithcardiovascularmortalityinrenaltransplantrecipientsaprospectivecohortstudy AT bakkerstephanjl posttransplantationplasmamalondialdehydeisassociatedwithcardiovascularmortalityinrenaltransplantrecipientsaprospectivecohortstudy |